Is Teladoc Stock a Buy Now?
With Teladoc Health's (NYSE: TDOC) stock price down by more than 70% over the past 12 months, shareholders are likely to be searching hard for any reasons for optimism. To that end, the telehealth company's rising sales serve as a bright spot. In the third quarter, its revenue grew by 81% year over year to $522 million, and investors are likely to see more big growth when it reports on Q4 in February.
But how much does a rising top line matter if the stock keeps tanking all the while?
Image source: Getty Images.
Source Fool.com
